Aldo keto reductases 1B in endocrinology and metabolism
The aldose reductase (human AKR1B1/mouse Akr1b3) has been the focus of many research because of its role in diabetic complications. The starting point of these alterations is the massive entry of glucose in polyol pathway where it is converted into sorbitol by this enzyme. However, the issue of aldo...
Main Authors: | Emilie ePastel, Jean-Christophe ePointud, Fanny eVolat, Antoine eMartinez, Anne-Marie eLefrançois-Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00148/full |
Similar Items
-
Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition
by: Francesc Xavier Ruiz, et al.
Published: (2021-12-01) -
Role of aldo-keto reductase enzymes in mediating the timing of parturition
by: Michael C. Byrns
Published: (2012-01-01) -
Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
by: Brian eLaffin, et al.
Published: (2012-06-01) -
The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017-01-01) -
In Search of Differential Inhibitors of Aldose Reductase
by: Francesco Balestri, et al.
Published: (2022-03-01)